Given reports of IGF2 deficits in non-aged female infertility patients (e.g., oocytes from obese women), perhaps IGF2 supplementation in in vitro culture systems could improve the yield of quality embryos derived from obese women, which should also benefit implantation success and improve overall pregnancy outcomes. This evidence concerns the gene IGF2 and female infertility.